cipla.com Report : Visit Site

Technical data of the cipla.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host cipla.com. Currently, hosted in India and its service provider is Netmagic Datacenter .

the related websites

drugsupdate.com bloomberg.com brown.rice.edu oddwayinternational.com mypersonalbest.org.uk trustpaybiz.com jarmc.org cuea.edu elindiocatering.com nptc.org dsawa.asn.au perustar.com falck.lk rolser.com communitywest.com.au maxicrop.co.uk ffrf.org 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

corporate information at a glance credo board of directors committees of board management council quality partnership plants & capacities code of conduct cipla blog caring for life leaders speak in the news life at cipla media media releases media contacts media photos media kit careers our businesses geographies india south africa europe north america australia products international strategic business units api api finder respiratory cipla global access cipla new ventures r&d; leader in drug delivery formulation development api development platform technology technology videos therapies women's health devices cardiovascular children's health dermatology and cosmetology diabetes hiv/aids hepatitis oncology infectious diseases & critical care malaria neurosciences ophthalmology osteoporosis respiratory urology investor information financial results annual report and chairman’s speech conference call transcripts shareholder information unclaimed data csr vision & mission palliative care cipla partners with mannkind for exclusive marketing, distribution of afrezza®, innovative inhaled insulin cipla limited today announced... read more strong legacy. stronger future in 1981, s.v. iyer’s son was diagnosed with thalassaemia major. there were no long-term treatment options in india at that time... read more forbes emergent 25: under samina vaziralli’s guidance, cipla gets a shot-in-the-arm from us acquisition read more breathing new life into asthma care in a country like india it is not surprising that breathing conditions such as asthma, wheezing, copd and bronchitis abound. the air quality in many... read more investor information press releases investor presentations annual report financials cipla q3 fy18 results reflect continuously improving quality of earnings backed by strong momentum across key regions february 07 2018 cipla q2 fy18 results demonstrate strong growth across businesses and the benefit of operating leverage november 07 2017 cipla announces q1fy 18 results strong focus on operational efficiency drives margin expansion august 07 2018 cipla q3 fy17 results demonstrate continued improvement in profitability february 08 2017 investor presentation q3 fy 18 february 07 2018 investor presentation q2 fy 18 november 07 2018 investor presentation q1 fy 18 august 11 2018 investor presentation q4 fy 17 may 25 2017 annual report 2016-17 annual report 2015-16 annual report 2014-15 extract of consolidated unaudited financial results 31st december 2017 extract of consolidated unaudited financial results 30th september 2017 extract of consolidated unaudited financial results 30th june 2017 extract of consolidated audited financial results 31st march 2017 investor information cipla: nse and cipla: bse quotes by tradingview social responsibility has been at the core of cipla, since inception. cipla foundation takes the company’s socially conscious legacy forward through initiatives in: health education skilling explore » cipla @cipla_global @theginger_t hey, we would require the product name and its batch number. also, kindly dm us your contact details for any further clarification. 0 0 posted: 11 hours ago cipla @cipla_global @theginger_t hi, please share your contact details along with your area code. our team will assist you. 0 0 posted: 11 hours ago cipla @cipla_global here’s your opportunity to work with a global pharmaceutical company. walk in for an interview on 15th june 2018, at our bommasandra, karnataka, unit. more details on the image. https://t.co/eubsiiepym 1 3 posted: 13 hours ago samina vaziralli @saminavaziralli greatly enjoyed my visit to our who-approved ciplaqcil site that manufactures arvs, antimalarials & hepatitis medicines. going beyond medicines, we provide internships, skilling, education - giving back to community in true @cipla_global tradition. #caringforlife https://t.co/jjsw80thee cipla retweeted 9 0 posted: 14 hours ago samina vaziralli @saminavaziralli uganda & @cipla_global celebrating proud decade-long partnership for accessible healthcare & mutual empowerment in truest sense. warm welcome & meaningful conversations with prime minister @ruhakanar & minister of health @janeruth_aceng on our shared purpose of #caringforlife https://t.co/ggvl0kbb23 cipla retweeted 18 0 posted: 14 hours ago forbes india @forbes_india . @saminavaziralli: @cipla_global's guiding force https://t.co/fsjlq6kkce | @forbesasia https://t.co/etil9mlpxp cipla retweeted 3 0 posted: 14 hours ago cipla @cipla_global cipla receives final @us_fda approval for generic isuprel® (isoproterenol hydrochloride injection usp, 0.2mg/ml) https://t.co/r2qqj8nio8 https://t.co/4zuayfkylb 7 25 posted: yesterday cipla @cipla_global from #uquittoiquit to #ekcigarettekam, @nicotex_in's messaging through ad campaigns has been based on consumer insights. the campaigns have aimed at motivating people to quit & reassuring them quitting is possible. read more. https://t.co/lz5je9vdco 1 4 posted: yesterday cipla @cipla_global next stop for b.e.s.t., go tobacco-free. on #worldnotobaccoday, b.e.s.t. along with cipla set forth on a journey to reduce the dependence of its workforce on tobacco with nicotine replacement kits and a mobile app. read more. https://t.co/qz2h1iafv6 2 8 posted: 2 days ago corporate information at a glance board of directors partnership code of conduct quality plants & capacities our businesses geographies strategic business units cipla new ventures r & d leader in drug delivery formulation development api development regulatory platform technology csr csr report palliative care therapies cardiovascular children's health dermatology and cosmetology diabetes hiv/aids hepatitis infectious diseases & critical care malaria neurosciences oncology ophthalmology osteoporosis respiratory urology women's health devices investor information financial results annual report and chairman’s speech conference call transcripts financial news and announcements -- shareholder information unclaimed dividend quick links www.act-c.in www.breathefree.com www.carebeyondcure.org www.ciplamed.com get social © copyright 2018 cipla inc. all rights reserved privacy policy disclaimer contact us site map caution notice - "recruitment fraud" digital partner : indus net technologies

URL analysis for cipla.com

https://www.cipla.com/uploads/investor/1486553416_press%20release%20-%20q3fy17.pdf
https://www.cipla.com/en///en/careers.html
https://www.cipla.com/en///en/therapies/women-s-health.html
https://www.cipla.com/en///en/investor-information.html
https://www.cipla.com/en///en/therapies.html
https://www.cipla.com/uploads/investor/1472556329_annual%20report_2015-16%201.pdf
https://www.cipla.com/en///en/privacy-policy.html
https://www.cipla.com/en///en/therapies/urology.html
https://www.cipla.com/en///en/our-businesses/strategic-business-units/api.html
https://www.cipla.com/uploads/investor/1495713440_cipla%20-%20q4fy17%20investor%20presentation.pdf
https://www.cipla.com/en///en/contact-us.html
https://www.cipla.com/en///en/therapies/hepattis1.html
https://www.cipla.com/en///en/corporate-information/code-of-conduct.html
https://www.cipla.com/en///en/csr/overview.html?id=31
https://www.cipla.com/uploads/investor/1500033215_annual%20report%202016-17.pdf

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: CIPLA.COM
Registry Domain ID: 4381049_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2017-07-19T07:50:59Z
Creation Date: 1996-10-17T04:00:00Z
Registry Expiry Date: 2018-10-16T04:00:00Z
Registrar: Network Solutions, LLC.
Registrar IANA ID: 2
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.CIPLA.COM
Name Server: NS2.CIPLA.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-23T08:26:11Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Network Solutions, LLC.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =cipla.com

  PORT 43

  TYPE domain

DOMAIN

  NAME cipla.com

  CHANGED 2017-07-19

  CREATED 1996-10-17

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS1.CIPLA.COM 118.67.249.189

  NS2.CIPLA.COM 113.30.141.16

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .